Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

76 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Uridine diphosphate glucuronosyl transferase 1 family polypeptide A1 gene (UGT1A1) polymorphisms are associated with toxicity and efficacy in irinotecan monotherapy for refractory pancreatic cancer.
Takahara N, Nakai Y, Isayama H, Sasaki T, Satoh Y, Takai D, Hamada T, Uchino R, Mizuno S, Miyabayashi K, Mohri D, Kawakubo K, Kogure H, Yamamoto N, Sasahira N, Hirano K, Ijichi H, Tada M, Yatomi Y, Koike K. Takahara N, et al. Among authors: uchino r. Cancer Chemother Pharmacol. 2013 Jan;71(1):85-92. doi: 10.1007/s00280-012-1981-0. Epub 2012 Sep 29. Cancer Chemother Pharmacol. 2013. PMID: 23053265 Clinical Trial.
A multicenter phase II trial of gemcitabine and candesartan combination therapy in patients with advanced pancreatic cancer: GECA2.
Nakai Y, Isayama H, Ijichi H, Sasaki T, Takahara N, Ito Y, Matsubara S, Uchino R, Yagioka H, Arizumi T, Hamada T, Miyabayashi K, Mizuno S, Yamamoto K, Kogure H, Yamamoto N, Hirano K, Sasahira N, Tateishi K, Tada M, Koike K. Nakai Y, et al. Among authors: uchino r. Invest New Drugs. 2013 Oct;31(5):1294-9. doi: 10.1007/s10637-013-9972-5. Epub 2013 May 21. Invest New Drugs. 2013. PMID: 23690239 Clinical Trial.
A retrospective study of S-1 and oxaliplatin combination chemotherapy in patients with refractory pancreatic cancer.
Takahara N, Isayama H, Nakai Y, Sasaki T, Hamada T, Uchino R, Mizuno S, Miyabayashi K, Kogure H, Yamamoto N, Sasahira N, Hirano K, Ijichi H, Tateishi K, Tada M, Koike K. Takahara N, et al. Among authors: uchino r. Cancer Chemother Pharmacol. 2013 Nov;72(5):985-90. doi: 10.1007/s00280-013-2278-7. Epub 2013 Sep 1. Cancer Chemother Pharmacol. 2013. PMID: 23995699
A retrospective analysis of early CA19‑9 change in salvage chemotherapy for refractory pancreatic cancer.
Nakai Y, Isayama H, Sasaki T, Takahara N, Hamada T, Uchino R, Mizuno S, Miyabayashi K, Yamamoto K, Mohri D, Kogure H, Yamamoto N, Hirano K, Ijichi H, Tateishi K, Tada M, Koike K. Nakai Y, et al. Among authors: uchino r. Cancer Chemother Pharmacol. 2013 Dec;72(6):1291-7. doi: 10.1007/s00280-013-2313-8. Cancer Chemother Pharmacol. 2013. PMID: 24121456
Intravenous and intraperitoneal paclitaxel with S-1 for refractory pancreatic cancer with malignant ascites: an interim analysis.
Takahara N, Isayama H, Nakai Y, Sasaki T, Ishigami H, Yamashita H, Yamaguchi H, Hamada T, Uchino R, Mizuno S, Miyabayashi K, Mohri D, Kawakubo K, Kogure H, Yamamoto N, Sasahira N, Hirano K, Ijichi H, Tateishi K, Tada M, Kitayama J, Watanabe T, Koike K. Takahara N, et al. Among authors: uchino r. J Gastrointest Cancer. 2014 Sep;45(3):307-11. doi: 10.1007/s12029-014-9603-1. J Gastrointest Cancer. 2014. PMID: 24676891 Clinical Trial.
Smoking, family history of cancer, and diabetes mellitus are associated with the age of onset of pancreatic cancer in Japanese patients.
Mizuno S, Nakai Y, Isayama H, Kawahata S, Saito T, Takagi K, Watanabe T, Uchino R, Hamada T, Miyabayashi K, Kogure H, Sasaki T, Yamamoto N, Sasahira N, Hirano K, Tsujino T, Ijichi H, Tateishi K, Tada M, Koike K. Mizuno S, et al. Among authors: uchino r. Pancreas. 2014 Oct;43(7):1014-7. doi: 10.1097/MPA.0000000000000158. Pancreas. 2014. PMID: 24979618
Gemcitabine and S-1 versus gemcitabine and cisplatin treatment in patients with advanced biliary tract cancer: a multicenter retrospective study.
Takahara N, Isayama H, Nakai Y, Sasaki T, Ishigaki K, Saito K, Akiyama D, Uchino R, Mizuno S, Yagioka H, Kogure H, Togawa O, Matsubara S, Ito Y, Toda N, Tada M, Koike K. Takahara N, et al. Among authors: uchino r. Invest New Drugs. 2017 Jun;35(3):269-276. doi: 10.1007/s10637-017-0430-7. Epub 2017 Jan 26. Invest New Drugs. 2017. PMID: 28124197
CA19-9 kinetics during systemic chemotherapy in patients with advanced or recurrent biliary tract cancer.
Takahara N, Nakai Y, Isayama H, Sasaki T, Saito K, Noguchi K, Suzuki T, Nakamura T, Sato T, Ishigaki K, Hakuta R, Takeda T, Uchino R, Mizuno S, Kogure H, Tada M, Koike K. Takahara N, et al. Among authors: uchino r. Cancer Chemother Pharmacol. 2017 Dec;80(6):1105-1112. doi: 10.1007/s00280-017-3456-9. Epub 2017 Oct 16. Cancer Chemother Pharmacol. 2017. PMID: 29038848
A phase II trial of gemcitabine, S-1 and LV combination (GSL) therapy in patients with advanced pancreatic cancer.
Saito K, Isayama H, Nakai Y, Takahara N, Ishigaki K, Takeda T, Hakuta R, Saito T, Uchino R, Kishikawa T, Hamada T, Mizuno S, Sasaki T, Kogure H, Matsubara S, Yamamoto N, Ijichi H, Tateishi K, Tada M, Koike K. Saito K, et al. Among authors: uchino r. Invest New Drugs. 2019 Apr;37(2):338-344. doi: 10.1007/s10637-018-0691-9. Epub 2018 Nov 9. Invest New Drugs. 2019. PMID: 30411217 Clinical Trial.
Endoscopic removal of a piece of retained pancreatic stent with a novel new technique: turned guide-wire looping method.
Takahara N, Isayama H, Sasahira N, Hamada T, Uchino R, Mizuno S, Miyabayashi K, Mohri D, Kawakubo K, Kogure H, Sasaki T, Yamamoto N, Nakai Y, Hirano K, Tada M, Koike K. Takahara N, et al. Among authors: uchino r. Endoscopy. 2012;44 Suppl 2 UCTN:E401. doi: 10.1055/s-0032-1309897. Epub 2012 Nov 20. Endoscopy. 2012. PMID: 23169035 No abstract available.
76 results